P Samaras
Nelfinavir and lenalidomide/dexamethasone in patients with lenalidomide-refractory multiple myeloma. A phase I/II Trial (SAKK 39/10)
Hitz F, Driessen C, Mey U, Samaras P, Vilei S, Stüdeli S, Rondeau S, Seipel K, Novak U, Silzle T, Besse L, Hess D, Pabst T, Kraus M, Swiss Group for Clinical Cancer Research SAKK. Nelfinavir and lenalidomide/dexamethasone in patients with lenalidomide-refractory multiple myeloma. A phase I/II Trial (SAKK 39/10). Blood Cancer J 2019; 9:70.
Aug 27, 2019Nelfinavir and lenalidomide/dexamethasone in patients with lenalidomide-refractory multiple myeloma. A phase I/II Trial (SAKK 39/10)
Aug 27, 2019Blood Cancer J 2019; 9:70
Hitz Felicitas, Driessen Christoph, Mey U, Samaras P, Vilei S Berardi, Stüdeli S, Rondeau S, Seipel K, Novak U, Silzle Tobias, Besse Lenka, Hess Dagmar, Pabst T, Kraus Marianne, Swiss Group for Clinical Cancer Research SAKK
Autologous hematopoietic stem cell transplantation for intravascular large B-cell lymphoma: the European Society for Blood and Marrow Transplantation experience
Meissner J, Montoto S, Samaras P, Robinson S, Pioltelli P, Pabst T, Mohty M, Ludwig H, Hess U, Finke J, Delage J, Cornelissen J, Abecasis M, Laboure G, Kanfer E, Boumendil A, Dietrich S, Finel H, Dreger P. Autologous hematopoietic stem cell transplantation for intravascular large B-cell lymphoma: the European Society for Blood and Marrow Transplantation experience. Bone Marrow Transplant 2016; 52:650-652.
Dec 19, 2016Autologous hematopoietic stem cell transplantation for intravascular large B-cell lymphoma: the European Society for Blood and Marrow Transplantation experience
Dec 19, 2016Bone Marrow Transplant 2016; 52:650-652
Meissner J, Montoto S, Samaras P, Robinson S, Pioltelli P, Pabst T, Mohty M, Ludwig H, Hess Urs, Finke J, Delage J, Cornelissen J, Abecasis M, Laboure G, Kanfer E, Boumendil A, Dietrich S, Finel H, Dreger P
Recent advances and future challenges in the treatment of hepatocellular and biliary tract carcinomas
Köberle D, Samaras P. Recent advances and future challenges in the treatment of hepatocellular and biliary tract carcinomas. Memo 4 2011; 4:94-97.
Jan 1, 2011Recent advances and future challenges in the treatment of hepatocellular and biliary tract carcinomas
Jan 1, 2011Memo 4 2011; 4:94-97
Köberle Dieter, Samaras P
Risk-adapted FDG-PET/CT-based follow-up in patients with diffuse large B-cell lymphoma after first-line therapy
Petrausch U, Renner C, Mischo A, Hany T, Knuth A, Soyka J, Veit-Haibach P, Haile S, Samaras P, Schäefer N. Risk-adapted FDG-PET/CT-based follow-up in patients with diffuse large B-cell lymphoma after first-line therapy. Ann Oncol 2010; 21:1694-8.
Feb 5, 2010Risk-adapted FDG-PET/CT-based follow-up in patients with diffuse large B-cell lymphoma after first-line therapy
Feb 5, 2010Ann Oncol 2010; 21:1694-8
Petrausch U, Renner C, Mischo A, Hany T F, Knuth A, Soyka J D, Veit-Haibach P, Haile Sarah, Samaras P, Schäefer N G